Koyfin Home > Directory > Health Care > Abbott Laboratories > Long-Term Investments

Abbott Laboratories Long-Term Investments Chart (ABT)

Abbott Laboratories annual/quarterly Long-Term Investments from 2010 to 2020.
  • Abbott Laboratories Long-Term Investments for the quarter ending June 06, 2020 was $691m a 10.56% increase of 73m year over year
  • Abbott Laboratories Long-Term Investments for the last 12 months ending June 06, 2020 was $691m a 10.56% increase of 73m year over year
  • Abbott Laboratories Annual Long-Term Investments for 2019 was $585m a -0.85% decrease of -5m from 2018
  • Abbott Laboratories Annual Long-Term Investments for 2018 was $590m a 11.86% increase of 70m from 2017
  • Abbott Laboratories Annual Long-Term Investments for 2017 was $520m a -468.27% decrease of -2,435m from 2016
Other Cash Flow Metrics:
  • Abbott Laboratories Cash Flow from Operations for the quarter ending September 09, 2018 was $2,183m a 8.15% increase of 178m year over year
  • Abbott Laboratories Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,647m a 6.17% increase of 102m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Long-Term Investments Data

06/2020$691m
03/2020$717m
12/2019$585m
09/2019$618m
06/2019$531m
03/2019$539m
12/2018$590m
09/2018$621m
06/2018$600m
03/2018$547m

Annual ABT Long-Term Investments Data

2019$585m
2018$590m
2017$520m
2016$2,955m
2015$4,157m
2014$330m
2013$206m
2012$459m
2011$976m
2010$440m